Skip to main content

Table 1 Demographic characteristics of the study children.

From: Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age

Characteristics

PCV-7 group (n = 811)

Control group (n = 744)

P

Males (%)

476 (58.7)

413 (55.5)

0.22

Age at vaccination, median days (range)

   

First dose

82 (75–104)

82 (76–103)

0.96

Second dose

140 (128–155)

143 (130–158)

0.93

Third dose

340 (328–361)

343 (331–364)

0.92

Breast-feeding for at least three months, No. (%)

551 (67.9)

476 (64.1)

0.11

Living in urban area, No. (%)

527 (65.0)

498 (66.9)

0.44

Mother's age, median years (range)

33 (24–49)

33 (20–46)

0.96

Father's age, median years (range)

35 (21–50)

35 (21–51)

0.99

No. of persons in household, median (range)

3 (2–4)

3 (2–4)

1.00

No. of siblings, median (range)

1 (0–2)

1 (0–2)

1.00

Children with a smoker in the family, No. (%)

194 (23.9)

182 (24.5)

0.84

Children attending day-care, No. (%)

284 (35.0)

231 (31.0)

0.10

Duration of day care attendance, No. (%)

   

0–6 months

79 (9.7)

65 (8.7)

0.55

7–12 months

33 (4.1)

44 (5.9)

0.11

13–18 months

111 (13.7)

94 (12.6)

0.59

19–24 months

78 (9.6)

58 (7.8)

0.23

Vaccinated against influenza, No. (%)

12 (1.5)

10 (1.3)

0.99

  1. No significant between-group differences.